%0 Journal Article
%T Influence of Distinct Radiotherapy Techniques to Induce Second Cancer Risks in Left Breast Cancer
%A Raghda A. Elgendy
%A Wahib M. Attia
%A Ehab M. Attalla
%A Mostafa A. Elnaggar
%J International Journal of Medical Physics,Clinical Engineering and Radiation Oncology
%P 193-202
%@ 2168-5444
%D 2018
%I Scientific Research Publishing
%R 10.4236/ijmpcero.2018.72017
%X Influence of distinct
radiotherapy techniques to induce second cancer risks in left breast cancer. Material
and methods: Ten female patients with intact left breast cancer</span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">.</span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"> Two treatment plans for
each patient</span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">:</span></span></span><span><span><span style=\"font-family:&quot;\"> </span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">1)</span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"> two tangential beams
3D-Conformal radiotherapy, </span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">2)</span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"> intensity-modulated radiotherapy (IMRT) plan. Estimation of second cancer risk
from Organ equivalent dose models (OEDs) in three dose-response model for
organs at risk in left breast cases. Results: The P-value for OED models in
3D-IMRT for left lung, both lung, heart, right lung, right breast, thyroid,
liver and spinal cord in linear dose model </span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">was </span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">0.016, 0.005, 0.019, 3.95E</span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">-</span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">06, 5.79E</span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">-</span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">07, 0.003, 1.78E</span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span
%K Breast Cancer
%K Second Cancer Risks
%K 3DCRT
%K 7 Field IMRT
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=84876